Methyl Benzoate

Methyl Benzoate

SCHEMBL6426649

COC(=O)c1ccccc1.O=C1CSC(=S)N1

nearest known ligand 0.56

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 4/20 0.56
▸ LMNA P02545 1/20 0.56
▸ TSHR P16473 1/20 0.54
▸ GSK3A P49840 1/20 0.51
▸ GSK3B P49841 1/20 0.51
▸ TDP1 Q9NUW8 3/20 0.47
▸ HPGD P15428 3/20 0.47
▸ HTT P42858 2/20 0.47
▸ USP2 O75604 1/20 0.47
▸ SMN1; SMN2 Q16637 3/20 0.42
▸ L3MBTL1 Q9Y468 2/20 0.42
▸ MEN1 O00255 2/20 0.42
▸ KMT2A Q03164 2/20 0.42
▸ POLB P06746 1/20 0.42
▸ RAB9A P51151 3/20 0.42
▸ MAPT P10636 3/20 0.42
▸ CASP3 P42574 1/20 0.42
▸ SENP8 Q96LD8 1/20 0.42
▸ SENP7 Q9BQF6 1/20 0.42
▸ SENP6 Q9GZR1 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Methyl Benzoate SCHEMBL6426788 0.85 ALDH1A1 (0.58) ALDH1A1LMNATSHRGSK3AGSK3B
Catechol SCHEMBL3758856 0.78 GSK3A (0.56) ALDH1A1LMNAGSK3AGSK3BTDP1
Rhodanine SCHEMBL1194879 0.76 GSK3A (0.75) ALDH1A1LMNAGSK3AGSK3BTDP1
Methyl Benzoate SCHEMBL27790353 0.74 TSHR (0.76) ALDH1A1LMNATSHRTDP1HPGD
Rhodanine SCHEMBL3083933 0.74 GSK3A (0.78) ALDH1A1LMNAGSK3AGSK3BTDP1
Methyl Benzoate SCHEMBL1332323 0.74 TSHR (1.00) ALDH1A1LMNATSHRTDP1HPGD
Methyl Benzoate SCHEMBL29831725 0.74 TSHR (1.00) ALDH1A1LMNATSHRTDP1HPGD
Methyl Benzoate SCHEMBL28537345 0.74 TSHR (1.00) ALDH1A1LMNATSHRTDP1HPGD
Methyl Benzoate SCHEMBL7200 0.74 TSHR (1.00) ALDH1A1LMNATSHRTDP1HPGD
Methyl Benzoate SCHEMBL29105567 0.74 TSHR (1.00) ALDH1A1LMNATSHRTDP1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050042674-A9 Common ligand mimics: thiazolidinediones and rhodanines TRIAD THERAPEUTICS, INC. 2005-02-24 — — US disclosed
US-20040009526-A1 Common ligand mimics: thiazolidinediones and rhodanines YU LIN (US) 2004-01-15 — — US disclosed
WO-2003072033-A2 COMMON LIGAND MIMICS: THIAZOLIDINEDIONES AND RHODANINES TRIAD THERAPEUTICS, INC. (US) 2003-09-04 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040009526-A1 Common ligand mimics: thiazolidinediones and rhodanines GPR65, NR2E3, FGFR3 ALDH1A1 1216/4885LMNA 4805/4885TSHR 31/4885
US-20050042674-A9 Common ligand mimics: thiazolidinediones and rhodanines GPR65, NR2E3, FGFR3 ALDH1A1 1216/4885LMNA 4805/4885TSHR 31/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback